Caffeine disposition in obesity.-Reference-Cited by-同舟云学术

Caffeine disposition in obesity.

Published:1985-07 Issue:1 Volume:20 Page:61-66
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Abernethy DR,Todd EL,Schwartz JB

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1985.tb02799.x/fullpdf

Reference35 articles.

1. Phenytoin disposition in obesity: Determination of loading dose;Abernethy;Clin. Res.,1983a

2. Alterations in drug distribution and clearance due to obesity;Abernethy;J. Pharmac. exp. Ther.,1981

3. Prolonged accumulation of diazepam in obesity;Abernethy;J. clin. Pharmac.,1983

4. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam;Abernethy;Clin. Pharmacokin.,1984

5. The effects of phenobarbital and β-naphthoflavone on the elimination kinetics and metabolite pattern in the beagle dog;Aldridge;Drug Metab. Disp.,1979

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of obese adults: Not only an increase in weight;Biomedicine & Pharmacotherapy;2023-10

2. Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals;Clinical Pharmacokinetics;2022-12-26

3. Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy;The Journal of Clinical Pharmacology;2022-07-07

4. Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing;Frontiers in Pharmacology;2022-02-25

5. Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing;2021-07-13